1,773
Views
42
CrossRef citations to date
0
Altmetric
Review Articles

Review for Diagnostics of the Year: Multimodal Imaging in Behçet Uveitis

, MD, , MD, , MD & , MD, FEBOpth
Pages 7-19 | Received 19 May 2016, Accepted 20 Jun 2016, Published online: 19 Aug 2016

REFERENCES

  • Evereklioglu C. Current concepts in the etiology and treatment of Behçet disease. Surv Ophthalmol. 2005;50(4):297–350.
  • Keino H, Okada AA. Behçet’s disease: global epidemiology of an Old Silk Road disease. Br J Ophthalmol. 2007;91(12):1573–1574.
  • Azizlerli G, Köse AA, Sarica R, et al. Prevalence of Behçet’s disease in Istanbul, Turkey. Int J Dermatol. 2003;42(10):803–806.
  • Takeuchi M, Kastner DL, Remmers EF. The immunogenetics of Behçet’s disease: A comprehensive review. J Autoimmun. 2015;64:137–148.
  • Marta M, Santos E, Coutinho E, et al. The role of infections in Behçet disease and neuro-Behçet syndrome. Autoimmun Rev. 2015;14(7):609–615.
  • Evereklioglu C. Ocular Behçet disease: current therapeutic approaches. Curr Opin Ophthalmol. 2011;22(6):508–516.
  • Tugal-Tutkun I, Onal S, Altan-Yaycioglu R, et al. Uveitis in Behçet disease: an analysis of 880 patients. Am J Ophthalmol. 2004;138(3):373–380.
  • Tugal-Tutkun I. Behçet’s uveitis. Middle East Afr J Ophthalmol. 2009;16(4):219–224.
  • Atmaca LS. Fundus changes associated with Behçet’s disease. Graefes Arch Clin Exp Ophthalmol. 1989;227(4):340–344.
  • Ozdal PC, Ortaç S, Taskintuna I, et al. Posterior segment involvement in ocular Behçet’s disease. Eur J Ophthalmol. 2002;12(5):424–431.
  • Tugal-Tutkun I, Gupta V, Cunningham ET. Differential diagnosis of Behçet uveitis. Ocul Immunol Inflamm. 2013;21(5):337–350.
  • Tugal-Tutkun I. Imaging in the diagnosis and management of Behçet disease. Int Ophthalmol Clin. 2012;52(4):183–190.
  • Namba K, Goto H, Kaburaki T, et al. A Major Review: Current Aspects of Ocular Behçet’s Disease in Japan. Ocul Immunol Inflamm. 2015;23 Suppl 1:S1–S23.
  • Yu HG, Kim MJ, Oh FS. Fluorescein angiography and visual acuity in active uveitis with Behçet disease. Ocul Immunol Inflamm. 2009;17(1):41–46.
  • Kang HM, Lee SC. Long-term progression of retinal vasculitis in Behçet patients using a fluorescein angiography scoring system. Graefes Arch Clin Exp Ophthalmol. 2014;252(6):1001–1008.
  • Kim M, Kwon HJ, Choi EY, et al. Correlation between fluorescein angiographic findings and visual acuity in Behçet retinal vasculitis. Yonsei Med J. 2015;56(4):1087–1096.
  • Keino H, Okada AA, Watanabe T, et al. Decreased ocular inflammatory attacks and background retinal and disc vascular leakage in patients with Behcet’s disease on infliximab therapy. Br J Ophthalmol. 2011;95(9):1245–1250.
  • Keino H, Okada AA, Watanabe T, et al. Long-term efficacy of infliximab on background vascular leakage in patients with Behçet’s disease. Eye (Lond). 2014;28(9):1100–1106.
  • Atmaca LS, Batioğlu F, Idil A. Retinal and disc neovascularization in Behçet’s disease and efficacy of laser photocoagulation. Graefes Arch Clin Exp Ophthalmol. 1996;234(2):94–99.
  • Tugal-Tutkun I, Onal S, Altan-Yaycioglu R, et al. Neovascularization of the optic disc in Behcet’s disease. Jpn J Ophthalmol. 2006;50(3):256–265.
  • Takeuchi M, Hokama H, Tsukahara R, et al. Risk and prognostic factors of poor visual outcome in Behcet’s disease with ocular involvement. Graefes Arch Clin Exp Ophthalmol. 2005;243(11):1147–1152.
  • Tugal-Tutkun I, Herbort CP, Khairallah M. The Angiography Scoring for Uveitis Working Group (ASUWOG). Scoring of dual fluorescein and ICG inflammatory angiographic signs for the grading of posterior segment inflammation (dual fluorescein and ICG angiographic scoring system for uveitis). Int Ophthalmol. 2010;30(5):539–553.
  • Leder HA, Campbell JP, Sepah YJ, et al. Ultra-wide-field retinal imaging in the management of non-infectious retinal vasculitis. J Ophthalmic Inflamm Infect. 2013;3(1):30.
  • Mesquida M, Llorenç V, Fontenla JR, et al. Use of ultra-wide-field retinal imaging in the management of active Behçet retinal vasculitis. Retina. 2014; 34(10): 2121–2127.
  • Matsuo T, Sato Y, Shiraga F, et al. Choroidal abnormalities in Behçet’s disease observed by simultaneous indocyanine green and fluorescein angiography with scanning laser ophthalmoscopy. Ophthalmology. 1999;106(2):295–300.
  • Gedik S, Akova Y, Yilmaz G, et al. Indocyanine green and fundus fluorescein angiographic findings in patients with active ocular Behcet’s disease. Ocul Immunol Inflamm. 2005;13(1):51–58.
  • Klaeger A, Tran VT, Hiroz CA, et al. Indocyanine green angiography in Behçet’s uveitis. Retina. 2000;20(3):309–314.
  • Atmaca LS, Sonmez PA. Fluorescein and indocyanine green angiography findings in Behçet’s disease. Br J Ophthalmol. 2003;87(12):1466–1468.
  • Bozzoni-Pantaleoni F, Gharbiya M, Pirraglia MP, et al. Indocyanine green angiographic findings in Behçet disease. Retina. 2001;21(3):230–236.
  • Gupta V, Al-Dhibi HA, Arevalo JF. Retinal imaging in uveitis. Saudi J Ophthalmol. 2014;28(2):95–103.
  • Ossewaarde-van Norel J, Camfferman LP, Rothova A. Discrepancies between fluorescein angiography and optical coherence tomography in macular edema in uveitis. Ophthalmol. 2012;154(2):233–239.
  • Kim BH, Shin JY, Yu HG. Discrepancy in fluorescein angiography and optical coherence tomography findings of macular edema in intermediate uveitis. Ocul Immunol Inflamm. 2015 Dec 8:1–7. [In press] doi:10.3109/09273948.2015.1063668
  • Kempen JH, Sugar EA, Jaffe GJ, et al. Fluorescein angiography versus optical coherence tomography for diagnosis of uveitic macular edema. Ophthalmology. 2013;120(9):1852–1859.
  • Ossewaarde-van Norel A, Rothova A. Imaging methods for inflammatory macular edema. Int Ophthalmol Clin. 2012;52(4):55–66.
  • B, Moshier E, Goldberg N, et al. Subretinal fluid in uveitic macular edema: effect on vision and response to therapy. Am J Ophthalmol. 2013;155(1):143–149.
  • Lehpamer B, Moshier E, Pahk P, et al. Epiretinal membranes in uveitic macular edema: effect on vision and response to therapy. Am J Ophthalmol. 2014;157(5):1048–1055.
  • Onal S, Tugal-Tutkun I, Neri P, et al. Optical coherence tomography imaging in uveitis. Int Ophthalmol. 2014;34(2):401–435.
  • Tortorella P, D’Ambrosio E, Iannetti L, et al. Correlation between visual acuity, inner segment/outer segment junction, and cone outer segment tips line integrity in uveitic macular edema. Biomed Res Int. 2015;2015:853728. doi:10.1155/2015/853728.
  • Atmaca LS, Batioglu F, Muftuoglu O. Fluorescein angiography and optical coherence tomography in ocular Behçet’s disease. A preliminary study. Adv Exp Med Biol. 2003;528:355–360.
  • Takeuchi M, Iwasaki T, Kezuka T, et al. Functional and morphological changes in the eyes of Behçet’s patients with uveitis. Acta Ophthalmol. 2010;88(2):257–262.
  • Unoki N, Nishijima K, Kita M, et al. Structural changes of fovea during remission of Behçet’s disease as imaged by spectral domain optical coherence tomography. Eye (Lond). 2010;24(6):969–975.
  • Yüksel H, Türkcü FM, Şahin M, et al. Inner and outer segment junction (IS/OS line) integrity in ocular Behçet’s disease. Arq Bras Oftalmol. 2014;77(4):219–221.
  • Oray M, Onal S, Bayraktar S, et al. Nonglaucomatous localized retinal nerve fiber layer defects in Behçet uveitis. Am J Ophthalmol. 2015;159(3):475–481.
  • Keane PA, Karampelas M, Sim DA, et al. Objective measurement of vitreous inflammation using optical coherence tomography. Ophthalmology. 2014;121(9):1706–1714.
  • Keane PA, Balaskas K, Sim DA, et al. Automated analysis of vitreous inflammation using spectral-domain optical coherence tomography. Transl Vis Sci Technol. 42015;4(5):4. doi: 10.1167/tvst.4.5.4
  • Zarranz-Ventura J, Keane PA, et al. Evaluation of objective vitritis grading method using optical coherence tomography: Influence of phakic status and previous vitrectomy. Am J Ophthalmol 2016;161:172–180.
  • Ishikawa S, Taguchi M, Muraoka T, et al. Changes in subfoveal choroidal thickness associated with uveitis activity in patients with Behçet’s disease. Br J Ophthalmol. 2014;98(11):1508–1513.
  • Kim M, Kim H, Kwon HJ, et al. Choroidal thickness in Behcet’s uveitis: an enhanced depth imaging-optical coherence tomography and its association with angiographic changes. Invest Ophthalmol Vis Sci. 2013;54(9):6033–6039.
  • Ataş M, Yuvacı I, Demircan S, et al. Evaluation of the macular, peripapillary nerve fiber layer and choroid thickness changes in Behçet’s disease with spectral-domain OCT. J Ophthalmol. 2014;2014:865394. doi:10.1155/2014/865394.
  • Coskun E, Gurler B, Pehlivan Y, et al. Enhanced depth imaging optical coherence tomography findings in Behçet disease. Ocul Immunol Inflamm. 2013;21(6):440–445.
  • Branchini LA, Adhi M, Regatieri CV, et al. Analysis of choroidal morphologic features and vasculature in healthy eyes using spectral-domain optical coherence tomography. Ophthalmology. 2013;120(9):1901–1908.
  • Invernizzi A, Mapelli C, Viola F, et al. Choroidal granulomas visualized by enhanced depth imaging optical coherence tomography. Retina. 2015;35(3):525–531.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.